ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Shukra Pharmaceuticals has scheduled a board meeting on August 22, 2026, to approve the company's name change, object clause alterations, and AGM-related agendas.
Shukra Pharmaceuticals Ltd scheduled a board meeting for August 11, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Shukra Pharmaceuticals has scheduled a board meeting for June 10, 2026. Directors will discuss ratifying an allotment resolution and approving a draft postal ballot notice.
Shukra Pharmaceuticals Ltd has scheduled a Board Meeting on May 07, 2026. The board will consider audited financial results for the quarter and year ended March 31, 2026, and recommend a final dividend for FY 2025-26.